BOXER CAPITAL LLC
Q3 2020 Form 13-F
SAN DIEGO, CALIFORNIA
CIK 0001465837
· CRD 330106
· SEC-registered investment adviser
$2.9B Reported Value Total
Private funds (Form ADV)
2 funds
· $578.2M gross asset value
Hedge Fund: $578.2M
Source: Form ADV filed 2026-05-11
Reported value
$2.9B
Quarter over quarter
+13.5%
Holdings
75
Top-10 concentration
55.7%
Filing Structure
Reports holdings for
- Aviva Holdings Ltd. (not a 13F filer in our records) · File #28-17342 · Q1 2016 – Q3 2017 · declared by one filing
- Aviva Holdings Ltd. (not a 13F filer in our records) · Q4 2015 – Q4 2015 · declared by one filing
Key People
Form ADV owners & control persons
LLC Boxer Holdings Gp
MANAGER
Aaron Isaac Davis
MANAGER AND MEMBER
Tiffany Ann Ayres
CHIEF COMPLIANCE OFFICER AND LEGAL COUNSEL
Filing Navigation
13F Metrics
Loading 13F Metrics
Q3 2020 13F record
Q3 2020 13F filing summary
| Period of report | September 30, 2020 |
|---|---|
| Filed | November 16, 2020 |
| Form | 13F-HR |
| Reported value | $2.9B |
| Positions | 75 |
| Change in reported value | +27.2% |
| New positions | 17 |
| Exited positions | 7 |
| Position turnover | 29.3% |
| Top-10 concentration | 55.7% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q4 2024 13F
Filed Feb 14, 2025
|
0 | $0 |
|
Q3 2024 13F
Filed Nov 14, 2024
|
68 | $2.0B |
|
Q2 2024 13F
Filed Aug 14, 2024
|
61 | $1.9B |
|
Q1 2024 13F
Filed May 15, 2024
|
59 | $2.0B |
|
Q4 2023 13F
Filed Feb 14, 2024
|
52 | $2.0B |
|
Q3 2023 13F
Filed Nov 14, 2023
|
73 | $1.9B |
|
Q2 2023 13F
Filed Aug 14, 2023
|
79 | $2.2B |
|
Q1 2023 13F
Filed May 15, 2023
|
75 | $2.0B |
|
Q4 2022 13F
Filed Feb 14, 2023
|
71 | $1.9B |
|
Q3 2022 13F
Filed Nov 14, 2022
|
73 | $1.8B |
|
Q2 2022 13F
Filed Aug 15, 2022
|
76 | $1.6B |
|
Q1 2022 13F
Filed May 16, 2022
|
74 | $1.9B |
|
Q4 2021 13F
Filed Feb 14, 2022
|
70 | $2.6B |
|
Q3 2021 13F
Filed Nov 15, 2021
|
87 | $2.9B |
|
Q2 2021 13F
Filed Aug 16, 2021
|
95 | $2.8B |
|
Q1 2021 13F
Filed May 17, 2021
|
85 | $2.9B |
|
Q4 2020 13F
Filed Feb 16, 2021
|
78 | $3.1B |
|
Q3 2020 13F
Filed Nov 16, 2020
|
75 | $2.9B |
|
Q2 2020 13F
Filed Aug 14, 2020
|
65 | $2.3B |
|
Q1 2020 13F
Filed May 15, 2020
|
61 | $1.5B |
17 earlier quarters on file — choose one from the quarter menu above.
Top 20 holdings · Q3 2020
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | IMMU IMMUNOMEDICS INC | $382.6M | 13.22% |
| 2 | ONC BEIGENE LTD | $319.1M | 11.03% |
| 3 | MRTX MIRATI THERAPEUTICS INC | $293.2M | 10.13% |
| 4 | RVMD REVOLUTION MEDICINES INC | $115.2M | 3.98% |
| 5 | ITOS ITEOS THERAPEUTICS INC | $107.2M | 3.7% |
| 6 | SWTX SPRINGWORKS THERAPEUTICS INC | $99.0M | 3.42% |
| 7 | PMVP PMV PHARMACEUTICALS INC | $80.5M | 2.78% |
| 8 | SGEN SEATTLE GENETICS INC | $78.3M | 2.71% |
| 9 | ODT ODONATE THERAPEUTICS INC | $69.9M | 2.42% |
| 10 | SAGE SAGE THERAPEUTICS INC | $66.9M | 2.31% |
| 11 | BDTX BLACK DIAMOND THERAPEUTICS I | $60.9M | 2.1% |
| 12 | ALLK ALLAKOS INC | $55.0M | 1.9% |
| 13 | RLAY RELAY THERAPEUTICS INC | $53.3M | 1.84% |
| 14 | ICPT INTERCEPT PHARMACEUTICALS IN | $48.8M | 1.68% |
| 15 | NRIX NURIX THERAPEUTICS INC | $47.3M | 1.63% |
| 16 | ARGX ARGENX SE | $44.9M | 1.55% |
| 17 | CGEN COMPUGEN LTD | $38.7M | 1.34% |
| 18 | ESPR ESPERION THERAPEUTICS INC NE | $36.2M | 1.25% |
| 19 | RCUS ARCUS BIOSCIENCES INC | $35.7M | 1.23% |
| 20 | SNDX SYNDAX PHARMACEUTICALS INC | $33.8M | 1.17% |
Values as reported on the Q3 2020 Form 13F. Every position is in the holdings table below.